Observed psychopathology in offspring of parents with major depressive disorder, bipolar disorder and schizophrenia.


Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
04 2020
Historique:
pubmed: 24 5 2019
medline: 13 4 2021
entrez: 24 5 2019
Statut: ppublish

Résumé

Children of parents with mood and psychotic disorders are at elevated risk for a range of behavioral and emotional problems. However, as the usual reporter of psychopathology in children is the parent, reports of early problems in children of parents with mood and psychotic disorders may be biased by the parents' own experience of mental illness and their mental state. Independent observers rated psychopathology using the Test Observation Form in 378 children and youth between the ages of 4 and 24 (mean = 11.01, s.d. = 4.40) who had a parent with major depressive disorder, bipolar disorder, schizophrenia, or no history of mood and psychotic disorders. Observed attentional problems were elevated in offspring of parents with major depressive disorder, bipolar disorder and schizophrenia (effect sizes ranging between 0.31 and 0.56). Oppositional behavior and language/thought problems showed variable degrees of elevation (effect sizes 0.17 to 0.57) across the three high-risk groups, with the greatest difficulties observed in offspring of parents with bipolar disorder. Observed anxiety was increased in offspring of parents with major depressive disorder and bipolar disorder (effect sizes 0.19 and 0.25 respectively) but not in offspring of parents with schizophrenia. Our results suggest that externalizing problems and cognitive and language difficulties may represent a general manifestation of familial risk for mood and psychotic disorders, while anxiety may be a specific marker of liability for mood disorders. Observer assessment may improve early identification of risk and selection of youth who may benefit from targeted prevention.

Sections du résumé

BACKGROUND
Children of parents with mood and psychotic disorders are at elevated risk for a range of behavioral and emotional problems. However, as the usual reporter of psychopathology in children is the parent, reports of early problems in children of parents with mood and psychotic disorders may be biased by the parents' own experience of mental illness and their mental state.
METHODS
Independent observers rated psychopathology using the Test Observation Form in 378 children and youth between the ages of 4 and 24 (mean = 11.01, s.d. = 4.40) who had a parent with major depressive disorder, bipolar disorder, schizophrenia, or no history of mood and psychotic disorders.
RESULTS
Observed attentional problems were elevated in offspring of parents with major depressive disorder, bipolar disorder and schizophrenia (effect sizes ranging between 0.31 and 0.56). Oppositional behavior and language/thought problems showed variable degrees of elevation (effect sizes 0.17 to 0.57) across the three high-risk groups, with the greatest difficulties observed in offspring of parents with bipolar disorder. Observed anxiety was increased in offspring of parents with major depressive disorder and bipolar disorder (effect sizes 0.19 and 0.25 respectively) but not in offspring of parents with schizophrenia.
CONCLUSIONS
Our results suggest that externalizing problems and cognitive and language difficulties may represent a general manifestation of familial risk for mood and psychotic disorders, while anxiety may be a specific marker of liability for mood disorders. Observer assessment may improve early identification of risk and selection of youth who may benefit from targeted prevention.

Identifiants

pubmed: 31120010
pii: S0033291719001089
doi: 10.1017/S0033291719001089
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1050-1056

Subventions

Organisme : CIHR
ID : 124976
Pays : Canada
Organisme : CIHR
ID : 142738
Pays : Canada
Organisme : CIHR
ID : 148394
Pays : Canada

Auteurs

A Sandstrom (A)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Nova Scotia Health Authority, Halifax, NS, Canada.

L MacKenzie (L)

Nova Scotia Health Authority, Halifax, NS, Canada.
Department of Psychology, Dalhousie University, Halifax, NS, Canada.

A Pizzo (A)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Nova Scotia Health Authority, Halifax, NS, Canada.

A Fine (A)

Nova Scotia Health Authority, Halifax, NS, Canada.

S Rempel (S)

Nova Scotia Health Authority, Halifax, NS, Canada.

C Howard (C)

Nova Scotia Health Authority, Halifax, NS, Canada.

M Stephens (M)

Nova Scotia Health Authority, Halifax, NS, Canada.

V C Patterson (VC)

Nova Scotia Health Authority, Halifax, NS, Canada.
Department of Psychology, Dalhousie University, Halifax, NS, Canada.

V Drobinin (V)

Nova Scotia Health Authority, Halifax, NS, Canada.
Department of Medical Neuroscience, Dalhousie University, Halifax, NS, Canada.

H Van Gestel (H)

Nova Scotia Health Authority, Halifax, NS, Canada.

E Howes Vallis (E)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Nova Scotia Health Authority, Halifax, NS, Canada.

A Zwicker (A)

Nova Scotia Health Authority, Halifax, NS, Canada.
Department of Pathology, Dalhousie University, Halifax, NS, Canada.

L Propper (L)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
IWK Health Centre, Halifax, NS, Canada.

S Abidi (S)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
IWK Health Centre, Halifax, NS, Canada.

A Bagnell (A)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
IWK Health Centre, Halifax, NS, Canada.

D Lovas (D)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
IWK Health Centre, Halifax, NS, Canada.

J Cumby (J)

Nova Scotia Health Authority, Halifax, NS, Canada.

M Alda (M)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Nova Scotia Health Authority, Halifax, NS, Canada.

R Uher (R)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Nova Scotia Health Authority, Halifax, NS, Canada.

B Pavlova (B)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Nova Scotia Health Authority, Halifax, NS, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH